Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,825.00
-15.00 (-0.39%)
Nov 13, 2026, 3:30 PM JST
Kaken Pharmaceutical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Kaken Pharmaceutical stock has a consensus rating of "Hold" and an average price target of ¥4,575. The average 1-year stock price forecast is 19.61% higher than the current stock price, while the lowest is ¥4,000 (+4.58%) and the highest is ¥5,600 (+46.41%).
Price Target: ¥4,575 (+19.61%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Kaken Pharmaceutical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
87.50B
from 76.87B
Increased by 13.82%
Revenue Next Year
82.52B
from 87.50B
Decreased by -5.69%
EPS This Year
184.98
from 56.55
Increased by 227.09%
EPS Next Year
35.30
from 184.98
Decreased by -80.92%
Financial currency is JPY.